Orikine Bio Secures €800k Funding to Accelerate Development of ORK-1 for Autoimmune Diseases

Orikine Bio, a pioneering biopharmaceutical company focused on the discovery, research and development of precision-engineered bi-specific cytokine therapi...

December 04, 2024 | Wednesday | News
Polyrizon Signs Manufacturing Agreement with Eurofins CDMO for PL-14 Allergy Blocker Clinical Trial

Polyrizon Ltd. (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal hydrogels, anno...

December 03, 2024 | Tuesday | News
Inari Medical Receives National Reimbursement Approval for ClotTriever Thrombectomy System in Japan

Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering fr...

December 03, 2024 | Tuesday | News
Siemens Healthineers and DeepHealth Collaborate to Launch AI-Powered SmartTechnology™ for Enhanced Ultrasound Diagnostics

Siemens Healthineers and DeepHealth have signed a letter of intent to create AI-powered SmartTechnology™ to improve patient experience and operat...

December 02, 2024 | Monday | News
Renalys Pharma's Sparsentan Receives Orphan Drug Designation for Primary IgA Nephropathy in Japan

Renalys Pharma, Inc., a late-stage clinical biopharmaceutical company announces that sparsentan, in-licensed from Travere Therapeutics, Inc. ("Trav...

December 02, 2024 | Monday | News
Taiwan’s Formosa Pharmaceuticals Partners with Medvisis to Launch Innovative Ophthalmic Treatment in Switzerland and Liechtenstein

Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Medvisis Switze...

November 29, 2024 | Friday | News
European Commission Approves TEVIMBRA® for First-Line Treatment of Esophageal and Gastric Cancers

 BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines, announced ...

November 28, 2024 | Thursday | News
European Commission Approves Single-Vial, Fully Liquid Menveo® Vaccine for Protection Against Meningococcal Disease

GSK plc (LSE/NYSE: GSK) announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of Menveo (Meningococca...

November 28, 2024 | Thursday | News
Acadia Pharmaceuticals Licenses SAN711 from Saniona for Essential Tremor, Expanding Neurology Pipeline

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced it has entered into an exclusive worldwide license agreement with Saniona (OMX: SANION) for the develo...

November 27, 2024 | Wednesday | News
West China Lecheng Hospital Launches Vorasidenib, First-in-Class Targeted Therapy for IDH-Mutant Glioma

It was announced that West China Lecheng Hospital has successfully introduced Vorasidenib for treatment at clinical practices, and the treatment began at o...

November 25, 2024 | Monday | News
SCG Cell Thearapy Presents Promising Phase 1 Data for SCG101, a First-in-Class HBV-Specific TCR-T Therapy

SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company focused on developing innovative immunotherapies for infectious diseases and associa...

November 25, 2024 | Monday | News
DANNCE.AI Secures $2.6M Pre-Seed Funding to Transform Neurological Care with AI-Powered Movement Analysis

DANNCE.AI raised $2.6 million in pre-seed funding led by LDV Capital, following initial investment from Glasswing Ventures, with participation from The L...

November 22, 2024 | Friday | News
Pfizer Appoints Dr. Chris Boshoff to Lead Global R&D Strategy, Pursuing Breakthroughs in Oncology and Beyond

Pfizer Inc. (NYSE: PFE) announced that after a comprehensive internal and external selection process, the company is appointing Chris Boshoff, M.D., PhD, a...

November 21, 2024 | Thursday | News
EMA Committee Recommends Approval of Opdivo® + Yervoy® for First-Line Treatment of MSI-H/dMMR Metastatic Colorectal Cancer

 Bristol Myers Squibb (NYSE: BMY) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)...

November 18, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close